Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background and purpose: Activation of the pregnane X receptor (PXR) has been shown to protect against cholestatic hepatotoxicity. As PXR alters the expression of numerous hepatic bile acid transporters, we sought to delineate their potential role in hepatoprotection. Experimental approach: Wild‐type (PXR+/+) and PXR‐null (PXR‐/‐) mice were fed a 1% cholic acid (CA) diet with or without the PXR activator, PCN. Liver function was assessed along with the corresponding changes in hepatic gene expression. Key results: CA administration caused significant hepatotoxicity in PXR+/+ mice and was associated with induction of several FXR and PXR regulated genes, which encode for bile acid transport and metabolizing proteins. Compared to CA alone, co‐administration of PCN to CA‐fed PXR+/+ mice significantly decreased hepatotoxicity and was associated with induction of MRP3 mRNA as well as CYP3A11 mRNA and functional activity. Unexpectedly, PXR‐/‐ mice, which expressed significantly higher basal and CA‐induced levels of MRP2, MRP3, OSTα, OSTβ, OATP2 and CYP3A11, were dramatically less sensitive to CA hepatotoxicity than PXR+/+ mice. Conclusions: Protection of PXR+/+ mice against CA‐induced hepatotoxicity by PCN is associated with the induction of MRP3 and CYP3A11 expression. Resistance against CA‐induced hepatotoxicity in PXR‐/‐ mice may result from higher basal and induced expression of bile acid transporters, particularly MRP3. These findings emphasize the importance of transport by MRP3 and metabolism as major protective pathways against cholestatic liver injury. British Journal of Pharmacology (2007) 151, 367–376; doi:10.1038/sj.bjp.0707235
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916 · cited 3×
“BA hydroxylation and biosynthesis, as well as BA transporters including the multi-drug resistance associated proteins MRP2 (ABCC2) (Kast et al., 2002), MRP3 (ABCC3) (Teng et al.”
BackgroundInfluentialWagner, M., Halilbasic, E., Marschall, H., Zollner, G., Fickert, P., Langner, C., Zatloukal, K., Denk, H., & Trauner, M. (2005) · Hepatology · doi:10.1002/hep.20784 · Cited by 355 · cited 2×
“, 2006) and increased proportions of hydroxylated urinary BAs have been reported in PCN-treated bile duct ligated mice (Wagner et al., 2005).”
BackgroundGuo, G. L., Lambert, G., Negishi, M., Ward, J. M., Brewer, H. B., Kliewer, S. A., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307145200 · Cited by 312 · cited 1×
“Similar trends have been reported in other nuclear receptor knockout models (Guo et al., 2003; Saini et al., 2005; Marschall et al., 2006).”
ResultHoensch, H. P., Balzer, K., Dylewizc, P., Kirch, W., Goebell, H., & Ohnhaus, E. E. (1985) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544371 · Cited by 76 · cited 2×
“One well known PXR activator, rifampicin, is used clinically for the treatment of complications associated with cholestatic diseases (Hoensch et al., 1985) and lithocholic acid-induced liver injury is attenuated by the rodent PXR activator, 5-pregnen-3b-ol-20-one-16acarbonitrile (PCN) (Staudinger…”
Background
Cited by
Dawson, P. A., Lan, T., & Rao, A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900012-jlr200 · Cited by 680
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond
Beuers, U., Trauner, M., Jansen, P., & Poupon, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.023 · Cited by 537
“The potent PXR ligand 5-pregnen3b-ol-20-one-16a-carbonitrile (PCN) reduced (litho-)cholic acidinduced liver injury in wild-type mice, but not in PXR knockout mice [163,172].”
BackgroundPrimary biliary cholangitis: pathogenesis and therapeutic opportunities
Gulamhusein, A. F., & Hirschfield, G. M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0226-7 · Cited by 308
Nuclear receptors as therapeutic targets in cholestatic liver diseases
Zollner, G., & Trauner, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00030.x · Cited by 146
The xenobiotic receptors PXR and CAR in liver physiology, an update
Cai, X., Young, G. M., & Xie, W. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166101 · Cited by 84
Metadata
- Authors
- Teng, S., & Piquette‐Miller, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-06
- Volume
- 151
- Issue
- 3
- Pages
- 367-376
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1902431806
- Cited by
- 130
- References
- 4
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasis. https://app.cochat.ai/papers/10.1038/sj.bjp.0707235
- The paper
- Teng, S., & Piquette‐Miller, M. (2007). Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasis. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0707235
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.